Literature DB >> 15061824

The effect of vascular disease on late onset Parkinson's disease.

S Papapetropoulos1, J Ellul, A A Argyriou, P Talelli, E Chroni, T Papapetropoulos.   

Abstract

The clinical severity of late onset Parkinson's disease (PD) varies from patient to patient and it is further complicated by the increasing prevalence of accompanying disorders in the elderly. We set out to study the impact of ischemic heart disease, minor stroke, hypertension and diabetes mellitus in a group of late onset PD patients (age >or=70 years). Consecutive late onset PD patients seen in the Department of Neurology, Medical School of Patras, Greece were included in this study. We used very strict criteria to eliminate the possibility of including patients with vascular parkinsonism. Comparisons were made between groups of patients suffering with idiopathic Parkinson's disease (IPD) and the above-mentioned diseases. One hundred and sixty-seven consecutive late onset PD patients were included in this study. The most common accompanying disorders in our group were hypertension in 31 (18%) of the patients and minor stroke in 20 (12%). The Hoen and Yahr score in late onset IPD patients who suffered from minor stroke, ischemic heart disease or diabetes mellitus was significantly higher when compared with patients without the above disorders. The results clearly suggest that the presence of vascular disease on an IPD patient may aggravate PD severity. In clinical grounds, these findings can be proved significant since early and aggressive prevention of vascular disease and treatment of vascular risk may contribute in controlling symptom severity in PD.

Entities:  

Mesh:

Year:  2004        PMID: 15061824     DOI: 10.1046/j.1468-1331.2003.00748.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  22 in total

1.  Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats.

Authors:  J K Morris; N B Seim; G L Bomhoff; P C Geiger; J A Stanford
Journal:  Neurosci Lett       Date:  2011-09-21       Impact factor: 3.046

2.  Patterns of chronic venous insufficiency in the dural sinuses and extracranial draining veins and their relationship with white matter hyperintensities for patients with Parkinson's disease.

Authors:  Manju Liu; Haibo Xu; Yuhui Wang; Yi Zhong; Shuang Xia; David Utriainen; Tao Wang; E Mark Haacke
Journal:  J Vasc Surg       Date:  2014-03-19       Impact factor: 4.268

3.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

4.  Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.

Authors:  James W S Young; Rinku Sutradhar; Jagadish Rangrej; Connie Marras; Neil Fleshner; Shabbir M H Alibhai
Journal:  World J Urol       Date:  2017-02-15       Impact factor: 4.226

Review 5.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

6.  Insulin resistance impairs nigrostriatal dopamine function.

Authors:  J K Morris; G L Bomhoff; B K Gorres; V A Davis; J Kim; P-P Lee; W M Brooks; G A Gerhardt; P C Geiger; J A Stanford
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

7.  Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan.

Authors:  Yung-Chuang Hsu; Cheng-Wei Chang; Hsin-Lin Lee; Chuan-Chung Chuang; Hsien-Chung Chiu; Wan-Yun Li; Jorng-Tzong Horng; Earl Fu
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 8.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

9.  Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.

Authors:  Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Jose L Lanciego; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Age (Dordr)       Date:  2012-09-18

10.  Vascular risk factors aggravate the progression of Parkinson's disease: a five-year follow-up study in Chinese patients.

Authors:  Hai Jun Li; Ying Yu; Ying Chen; Hai Yan Liang
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.